| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18544290 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 110 journal articles in the PubMed database | Email to a friend | | |
| Rivers JK, Rosoph L, Provost N, et al.
Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head. [Journal Article]
J Cutan Med Surg 2008 May-Jun; 12(3):97-101.
Abstract | Full Citation | Find Related Articles | | Lee PK, Harwell WB, Loven KH, et al.
Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream. [Clinical Trial, Clinical Trial, Phase IV, Journal Article, Multicenter Study, Randomized Controlled Trial]
Dermatol Surg 2005 Jun; 31(6):659-64.
Abstract | Full Citation | Find Related Articles | | Stockfleth E, Sterry W, Carey-Yard M, et al.
Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. [JOURNAL ARTICLE]
Br J Dermatol 2007 Dec; 157(s2):41-46.
Abstract | Full Citation | | Alomar A, Bichel J, McRae S
Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. [JOURNAL ARTICLE]
Br J Dermatol 2007 May 14.
Abstract | Full Citation | | Stockfleth E, Meyer T, Benninghoff B, et al.
A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Arch Dermatol 2002 Nov; 138(11):1498-502.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Korman N, Moy R, Ling M, et al.
Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Arch Dermatol 2005 Apr; 141(4):467-73.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lebwohl M, Dinehart S, Whiting D, et al.
Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Am Acad Dermatol 2004 May; 50(5):714-21.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Szeimies RM, Gerritsen MJ, Gupta G, et al.
Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Am Acad Dermatol 2004 Oct; 51(4):547-55.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ulrich C, Bichel J, Euvrard S, et al.
Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. [JOURNAL ARTICLE]
Br J Dermatol 2007 Dec; 157(s2):25-31.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
